Totaligent extends GloMed joint venture LOI deadline to April 22, 2026

Totaligent, Inc.

Extension Amendment moves target closing date from March 22 to April 22, 2026.
Binding exclusivity period extended through April 22, 2026.
Delay attributed to ongoing due diligence and negotiations for definitive agreements.
All other terms of the original LOI remain unchanged.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Totaligent, Inc. amended Extension Amendment with GloMed Solutions Limited Liability Company (effective 2026-03-22).

Action: amendment
Counterparty: GloMed Solutions Limited Liability Company
Effective: 2026-03-22

Exact text from the filing

On March 22, 2026, Totaligent, Inc. (the “Company”) entered into an Extension Amendment (the “Amendment”) to the Binding Letter of Intent dated February 22, 2026 (the “LOI”) with GloMed Solutions Limited Liability Company (“GloMed”).

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Totaligent, Inc. filing history →

Source: SEC EDGAR

accession 0001477932-26-001611

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.